期刊文献+

卵巢交界性上皮性肿瘤112例临床分析 被引量:2

The clinical analysis of 112 cases with ovarian borderline epithelial tumors
下载PDF
导出
摘要 目的探讨卵巢交界性上皮性肿瘤的临床特点及影响复发的相关因素。方法回顾性分析天津医科大学总医院2000年3月—2015年1月收治的112例卵巢交界性上皮性肿瘤的临床资料。结果 112例患者发病的平均年龄为(50.59±16.90)岁。FIGO临床分期Ⅰ期102例(91.07%),Ⅱ期4例(3.57%),Ⅲ期6例(5.36%);血清肿瘤标志物检查:行CA125检查患者102例,其中指标升高者27例,占26.47%;112例患者均进行手术治疗,年轻患者较年长患者更倾向于选择保守手术治疗;随访患者97例,其中5例复发,复发病例均行非保留生育功能手术。对不同临床病理因素下复发的病例进行对比,病理提示微浸润患者复发率高于无微浸润患者[37.50%(3/8)vs.2.25%(2/89),P=0.004];在浆液性交界性肿瘤患者中,微乳头型交界性浆液性肿瘤的复发率高于非微乳头型[40.00%(2/5)vs.0(0/41),P=0.019];7例行保留生育功能手术的患者成功妊娠。结论对于年轻有生育要求的卵巢交界性上皮性肿瘤患者可选择保留生育功能手术,结局安全有效。对于存在间质微浸润及微乳头型患者要警惕复发的可能。 Objective To determine the clinical features and the factors affecting the recurrence of ovarian borderlineepithelial tumors. Methods A retrospective data of 112 cases with ovarian borderline epithelial tumors admitted in GeneralHospital of Tianjin Medical University from 2000 to 2015 were analyzed. Results The average age was (50.59±16.90) years in112 patients with FIGO stage Ⅰof 102 (91.07%) patients, stage Ⅱof 4 (3.57%) and stage Ⅲof 6 (5.36%). The serum tumor marker(CA125) was examined in 102 patients, and 27 cases with the elevated indicator (26.47%). Surgical treatment was performed in112 patients. Younger patients were more likely to choose conservative surgery. Ninety-seven patients were followed up, and 5of them relapsed. Non fertility preserving surgery was performed in patients with recurrence. The recurrence rates of patients withdifferent clinical pathological factors were compared. The recurrence rate was higher in patients with micro infiltration than thatof patients without micro infiltration [37.50% (3/8) vs. 2.25% (2/89), P=0.004]. And the recurrence rate was higher in patientswith microemulsion type borderline serous tumor than that of patients with non-papillary tumors [40.00%(2/5)vs. 0(0/41),P=0.019]. Seven patients underwent conservative surgery had normal spontaneous pregnancy. Conclusion The fertility-sparingsurgery can be used as the treatment procedures for young patients, which is safe and effective. It is necessary to be on alert ofrecurrence for the cases with micropapillary pattern, and microinvasive tumor.
出处 《天津医药》 CAS 2016年第9期1092-1095,共4页 Tianjin Medical Journal
基金 国家自然科学基金青年项目(81402141) 天津市应用基础与前沿技术研究计划(15JCYBJC26600)
关键词 卵巢肿瘤 妇科外科手术 预后 卵巢交界性上皮性肿瘤 ovarian neoplasms gynecologic surgical procedures prognosis epithelialborderline ovarian tumors
  • 相关文献

参考文献10

  • 1李艺,崔恒,沈丹华,赵彦,魏丽惠,钱和年.卵巢交界性上皮性肿瘤的临床病理分析[J].中华妇产科杂志,2003,38(2):81-84. 被引量:15
  • 2Faluyi O,Mackean M,Gourley C,et al. Interventions for the treatmentof borderline ovarian tumours[J]. Cochrane Database Syst Rev,2010,2010(9):CD007696. doi:10.1002/14651858.CD007696.pub2.
  • 3任婕,楼江燕,刘辉,王平,张家文,杨开选,王红静,郄明蓉,彭芝兰.交界性卵巢上皮性肿瘤234例临床病理及预后分析[J].中华妇产科杂志,2009,44(2):116-120. 被引量:22
  • 4王伟明,蔡智慧,刘金,梁义娟,马幼菊,刘辉.联合检测血清DJ-1和CA125在上皮性卵巢肿瘤中的意义[J].天津医药,2015,43(11):1304-1307. 被引量:5
  • 5Helpman L,Beiner ME,Aviel- Ronen S,et al. Safety of ovarianconservation and fertility preservation in advanced borderlineovarian tumors[J]. Fertil Steril,2015,104(1):138- 144. doi:10.1016/j.fertnstert.2015.03.038.
  • 6陈瑞芳,朱婷婷,于海林,朱静,鹿欣.卵巢交界性肿瘤复发后再行保留生育功能手术12例临床分析[J].中华妇产科杂志,2014,49(4):254-259. 被引量:9
  • 7Vasconcelos I,Olschewski J,Braicu I,et al. A meta-analysis on theimpact of platinum- based adjuvant treatment on the outcome ofborderline ovarian tumors with invasive implants[J]. Oncologist,2015,20(2):151-158. doi:10.1634/theoncologist.2014-0144.
  • 8Maniar KP,Wang Y,Visvanathan K,et al. Evaluation ofmicroinvasion and lymph node involvement in ovarian serousborderline/atypical proliferative serous tumors:a morphologic andimmunohistochemical analysis of 37 cases[J]. Am J Surg Pathol,2014,38(6):743-755. doi:10.1097/PAS.0000000000000155.
  • 9何剑辉,张斌,徐嘉文,林伍梅,胡洁媚.卵巢交界性上皮性肿瘤58例临床分析[J].实用妇产科杂志,2013,29(10):765-768. 被引量:5
  • 10du Bois A,Ewald- Riegler N,de Gregorio N,et al. Borderlinetumours of the ovary:A cohort study of the ArbeitsgmeinschaftGyn-kologische Onkologie(AGO)Study Group[J]. Eur J Cancer,2013,49(8):1905-1914. doi:10.1016/j.ejca.2013.01.035.

二级参考文献53

  • 1Scully RE. International histological classification and staging of tumors: histological typing of ovarian tumors. Geneva: World Health Organization, 1999 : 12-15.
  • 2Changes in definitions of clinical staging for carcinoma of the cervix and the ovary: International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol, 1987,156:263-264.
  • 3Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary : a large population-based study. Gynecol Oncol,2006,103 : 841-847.
  • 4Fauvet R, Boccara J, Dufournet C, et a|. Laparoscopic management of borderline ovarian tumors: results of a French muhicenter study. Ann 0ncol,2005, 16:403-410.
  • 5Cusido M, Balaguero L, Hernandez G, et al. Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol,2007,104:617-622.
  • 6Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol, 1996, 20:1319- 1330.
  • 7Buttin BM, Herzog TJ, Powell MA, et al. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol, 2002, 99:11-17.
  • 8Berman JJ. Borderline ovarian tumor workshop, bethesda, maryland, 2003 [ J ]. Hum Patho1,2004,35 ( 8 ) :907 - 909.
  • 9Ha JE. Clinical analysis of borderline ovarian tumors[ J]. Eur J Gynae- col Oncol,2011,32( 1 ) :69 -72.
  • 10Somsukolrat S,Tuipae S. Prognostic factors and survival of borderline ovarian tumors in rajavithi hospital between 1979 2006 AD [ J]. J Med Assoc Thai, 2012,95 ( 9 ) : 1141 - 1148.

共引文献48

同被引文献31

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部